VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PASG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PASGPassage Bio, Inc.
$5.00$16M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPASGQuarterly Financials

Passage Bio, Inc. (PASG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Passage Bio, Inc. (PASG) quarterly income statement — complete revenue, gross profit & net income history

PASG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold129K00200K0719K00000000000000
COGS % of Revenue--------------------
Gross Profit-129K00-200K0-719K00000000000000
Gross Margin %--------------------
Gross Profit Growth %-100%------------------
Operating Expenses8.75M13.85M8.65M10.13M16.46M13.55M20.7M17.38M18.05M18.45M28.67M25.39M35.88M28.24M27.53M39.81M42.81M51.16M47.1M48.53M
OpEx % of Revenue--------------------
Selling, General & Admin4.79M4.92M4.35M4.52M6.08M3.99M7.25M6.51M6.51M6.29M8.18M8.06M7.75M6.79M10.66M12.99M15.1M17.19M14.98M15.42M
SG&A % of Revenue--------------------
Research & Development4.09M5.42M4.31M5.81M7.74M9.56M8.66M10.43M11.54M12.16M15.1M17.32M16.84M17.66M15.36M26.82M26.21M33.97M26.62M33.11M
R&D % of Revenue--------------------
Other Operating Expenses-129K1000K0-200K1000K01000K438K001000K01000K1000K1000K01000K01000K0
Operating Income-8.88M-13.85M-8.65M-10.33M-16.46M-14.27M-20.7M-17.38M-18.05M-18.45M-28.67M-25.39M-35.88M-28.24M-27.53M-39.81M-42.81M-51.16M-47.1M-48.53M
Operating Margin %--------------------
Operating Income Growth %46.05%2.96%58.19%40.53%8.81%22.64%27.8%31.55%49.7%34.69%-4.16%36.23%16.18%44.79%41.56%17.97%-9.96%-30.99%-64.52%-77.75%
EBITDA-8.75M-13.67M-8.35M-10.13M-16.26M-13.55M-19.94M-16.58M-17.24M-17.64M-27.71M-24.41M-34.91M-27.3M-26.6M-38.89M-41.93M-50.49M-46.64M-48.33M
EBITDA Margin %--------------------
EBITDA Growth %46.17%-0.89%58.16%38.88%5.72%23.18%28.04%32.07%50.6%35.38%-4.2%37.23%16.75%45.93%42.98%19.53%-8.28%-30.21%-64.49%-78.3%
D&A (Non-Cash Add-back)129K177K310K200K201K719K759K797K806K807K958K978K978K946K929K921K883K669K460K203K
EBIT-8.88M-10.34M-7.75M-9.38M-13.82M-13.03M-15.91M-16.94M-18.05M-18.45M-23.28M-25.39M-24.58M-22.14M-26.03M-39.81M-41.31M-50.16M-41.6M-48.53M
Net Interest Income0000700K800K1.1M1.2M1.3M-45K0001.17M825K270K1K6K186K99K
Interest Income0000700K800K1.1M1.2M1.3M1.5M0001.17M825K270K1K6K186K99K
Interest Expense0000000001.54M0000000000
Other Income/Expense1.32M865K906K949K1.05M1.54M1.36M1.39M1.34M1.69M1.56M1.53M1.54M1.17M825K270K1K6K186K99K
Pretax Income-7.56M-12.98M-7.75M-9.38M-15.4M-12.72M-19.34M-15.99M-16.71M-16.76M-27.11M-23.86M-34.34M-27.07M-26.7M-39.54M-42.81M-51.15M-46.91M-48.44M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-7.56M-12.98M-7.75M-9.38M-15.4M-12.72M-19.34M-15.99M-16.71M-16.76M-27.11M-23.86M-34.34M-27.07M-26.7M-39.54M-42.81M-51.15M-46.91M-48.44M
Net Margin %--------------------
Net Income Growth %50.93%-2.03%59.93%41.31%7.82%24.07%28.66%32.97%51.33%38.1%-1.53%39.67%19.79%47.08%43.09%18.36%-10.1%-31.35%-64.44%-78.25%
Net Income (Continuing)-7.56M-12.98M-7.75M-9.38M-15.4M-12.72M-19.34M-15.99M-16.71M-16.76M-27.11M-23.86M-34.34M-27.07M-26.7M-39.54M-42.81M-51.15M-46.91M-48.44M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.36-4.08-2.45-2.96-4.96-4.10-6.26-5.18-5.94-6.10-9.90-8.80-12.00-9.40-9.80-14.40-15.80-19.00-18.84-18.00
EPS Growth %52.42%0.49%60.86%42.86%16.5%32.79%36.77%41.14%50.5%35.11%-1.02%38.89%24.05%50.53%47.98%20%-1.22%-21.48%-49.52%-50%
EPS (Basic)-2.36-4.08-2.45-2.96-4.96-4.10-6.26-5.18-5.94-6.10-9.90-8.80-12.00-9.40-9.80-14.40-15.80-19.00-18.84-18.00
Diluted Shares Outstanding3.21M3.17M3.17M3.17M3.11M3.1M3.09M3.08M2.81M2.75M2.74M2.73M2.73M2.73M2.72M2.72M2.71M2.7M2.49M2.69M
Basic Shares Outstanding3.21M3.17M3.17M3.17M3.11M3.1M3.09M3.08M2.81M2.75M2.74M2.73M2.73M2.73M2.72M2.72M2.71M2.7M2.49M2.69M
Dividend Payout Ratio--------------------